Platinum Sponsors
AstraZeneca
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients.
- www.astrazeneca.com
- Booth no. 200
Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
- www.innovativemedicine.jnj.com
- Booth no. 150
Gold Sponsor
Regeneron
Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous FDA-approved treatments and product candidates in development.
- www.regeneron.com
- Booth no. 400
Silver Sponsors
Daiichi Sankyo
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need.
- www.daiichi-sankyo.eu
- Booth no. 420
Pfizer
Pfizer Oncology is at the forefront of a new era in cancer care. Driven by science, we are committed to accelerating breakthroughs to extend and improve the lives of people living with some of the world’s most common cancers.
- www.pfizer.com
- Booth no. 355
Bronze Sponsors
AbbVie Inc.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
- www.abbvie.com
- Booth no. 255
Accord Healthcare
Headquartered in the United Kingdom, Accord Healthcare is a fast-growing global pharmaceutical company that develops, manufactures and distributes medicines in over 85 countries worldwide, helping to improve access for patients to vital pharmaceutical care.
Our approach is agile and inventive, we’re driven to think differently by continuing to explore and deliver high quality medicines designed to benefit patients’ lives worldwide.
- www.accord-healthcare.com
- Booth no. 450
MSD
At MSD we use the power of leading-edge science to save and improve lives. We aspire to be the premier research-intensive biopharmaceutical company in the world. We are at the forefront of research, delivering innovative health solutions that advance disease prevention and treatment. We foster a diverse and inclusive workforce, operating responsibly to enable a safe, sustainable and healthy future.
- www.msd.com
- Booth no. 250
Novocure GmbH
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields (TTFields). TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms.
- www.novocure.com
- Booth no. 100
Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science. We provide a comprehensive suite of solutions for precision oncology, spanning early development through commercial strategy, encompassing companion diagnostics. Our leading clinical research services enable customers to accelerate innovation our advanced next-generation sequencing technology, Oncomine™ Solutions, enable laboratories everywhere to deliver genomic profiling from solid tumors and hematological cancers in as little as one day.
- www.thermofisher.com
- Booth no. 183
Exhibitors
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.
- www.bayer.com
- Booth no. 254
BeiGene
BeiGene, which plans to change its name to BeOne Medicines, is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. Our growing global team of nearly 11,000 colleagues spans five continents.
- www.beigene.com
- Booth no. 354
Genmab
Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer and other serious diseases. Genmab’s proprietary pipeline includes bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.
- www.genmab.com
- Booth no. 251
PharmaMar
PharmaMar is a biopharmaceutical company, focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. PharmaMar develops and commercializes Yondelis® in Europe. PharmaMar is also developing lurbinectedin in SCLC. It has been approved in 16 territories, including USA and Switzerland for the treatment of metastatic SCLC.
- www.pharmamar.com
- Booth no. 350
Pierre Fabre Laboratories
Pierre Fabre Laboratories, one of Europe's leading pharmaceutical companies has 43 years in oncology innovation. In 2023, 50% of R&D budget was allocated to targeted therapies. Its portfolio of oncology specialties covers colorectal, breast, melanoma, lung cancers and more. Founded in 1962, the company proudly manufactures 95% of its products in France, employing around 10.000 people worldwide.
- www.pierre-fabre.com
- Booth no. 252
Revolution Medicines
Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS companion inhibitors for use in combination treatment strategies.
- www.revmed.com
- Booth no. 352
Roche
Roche is a pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, hematology and beyond.
- www.roche.com
- Booth no. 253